Abstract
The aim of this study was to investigate the relationship of selenium concentration in blood components and tumour tissues of breast cancer patients and healthy volunteers (control), in Syria, using instrumental neutron activation analysis (INAA). Red blood cells and serum selenium concentrations were determined in 50 healthy volunteers aged 25-70 years and 70 breast cancer patients aged 25-84 years. Selenium levels were also measured in malignant and adjacent normal tissues from breast cancer patients. The accuracy of the analysis was evaluated by co-analyses of international reference materials. The results showed that selenium concentration in serum and RBC was significantly lower among breast cancer patients compared to healthy volunteers (P<0.001). The results also showed that the selenium concentration was significantly higher in the cancer tissues compared to adjacent normal tissues (P<0.001). We conclude that there is a good indication for selenium deviation in blood and malignant tissue of breast cancer patients compared to that of healthy volunteers.